Literature DB >> 7752296

Clonidine and opiate receptor antagonists in the treatment of heroin addiction.

G Gerra1, A Marcato, R Caccavari, B Fontanesi, R Delsignore, G Fertonani, P Avanzini, P Rustichelli, M Passeri.   

Abstract

Good results in detoxification methods have been reached using both together clonidine and opiate receptors antagonists. One hundred fifty-two heroin-abusing patients were studied evaluating withdrawal symptoms after therapy with (a) clonidine only, (b) clonidine and naltrexone, (c) clonidine and naloxone, and (d) placebos. Treatment results, emotional and behavioral changes, and involvement in psychosocial programs were evaluated after a 6-month follow-up. Although opiate antagonists were able to induce slight and transient withdrawal signs and symptoms, there was, in the group of patients treated with clonidine and naltrexone together, a low percentage of catabolites in urine and an improvement in mood and family relationships. Furthermore, the patients that underwent longer naltrexone treatment showed a stronger involvement in psychosocial programs, and even their relatives demonstrated more interest in the recovery program. A decrease in the difficulties of accepting an opiate antagonists treatment and a different evaluation of withdrawal syndrome were the results of an early use of naltrexone.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752296

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  10 in total

1.  Opiate detoxification under anaesthesia. No confusion and distress were intended.

Authors:  J Strang; J Bearn; M Gossop
Journal:  BMJ       Date:  1999-07-31

Review 2.  Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence.

Authors:  D M Tomkins; E M Sellers
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

Review 3.  Oral naltrexone maintenance treatment for opioid dependence.

Authors:  Silvia Minozzi; Laura Amato; Simona Vecchi; Marina Davoli; Ursula Kirchmayer; Annette Verster
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 4.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 5.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 6.  Treatment of heroin (diamorphine) addiction: current approaches and future prospects.

Authors:  Gerardo Gonzalez; Alison Oliveto; Thomas R Kosten
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

8.  Amantadine as Augmentation in Managing Opioid Withdrawal with Clonidine: a randomized controlled trial.

Authors:  Shahrokh Amiri; Ayyoub Malek; Farid Tofighnia; Bohlool Habibi Asl; Ali Seidy
Journal:  Iran J Psychiatry       Date:  2014-07

9.  Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.

Authors:  A S Reece
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-11-23

10.  The therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: a randomized clinical trial.

Authors:  Ayyoub Malek; Shahrokh Amiri; Bohlool Habibi Asl
Journal:  ISRN Psychiatry       Date:  2013-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.